INEPT
发表于 2025-3-21 18:19:12
书目名称Obesity影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0700108<br><br> <br><br>书目名称Obesity读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0700108<br><br> <br><br>
GEON
发表于 2025-3-21 22:27:37
The Biology of Weight Regulation and Genetic ResettingTM,ersonal choice than a fact of biology: once obesity is established at a certain level of adiposity dysfunction, the person with obesity rarely escapes its grip or consequences. This chapter discusses in detail the science of weight regulation, thescience of epigenetics, and the science behind the concept of genetic resetting..
圆木可阻碍
发表于 2025-3-22 03:58:12
Obesity-Related Diseases and Syndromes: Cancer, Endocrine Disease, Pulmonary Disease, Pseudotumor Ccancer, endocrine disease, polycystic ovarian syndrome, infertility, pulmonary disease, asthma, hyperventilation syndrome, venus thromboembolic disease, pseudotumor cerebrii, disordered sleep and sleep apnea.
Lobotomy
发表于 2025-3-22 04:55:24
Pediatric Obesity,emergence during childhood of specific adult obesity-related diseases. The unique challenges of managing childhood obesity are explored and the four stages of obesity intervention that all practitioners can use to diagnose and treat childhood and adolescent obesity are explained.
Minatory
发表于 2025-3-22 11:40:36
Beyond Traditional Management: The Use of Medications in the Treatment of Obesity,. Finally, this chapter explains the mechanism of action of FDA-approved medications for weight loss. As our understanding of obesity improves and the efficacy of prescription medications evolves our management strategies will improve as well, resulting in a positive and lasting impact on patients with obesity and on the disease itself.
Canyon
发表于 2025-3-22 15:15:38
http://reply.papertrans.cn/71/7002/700108/700108_6.png
Blood-Vessels
发表于 2025-3-22 19:05:56
Obesity-Related Diseases and Syndromes: Insulin Resistance, Type 2 Diabetes Mellitus, Non-alcoholicogy of obesity as it relates to non-alcoholic fatty liver disease (NAFLD). The chapter ends with specific discussions about the relationships between obesity and other obesity-related diseases, including hypertension, dyslipidemia, atherosclerosis, coronary heart disease and stroke.
objection
发表于 2025-3-23 00:08:21
Book 2016 newest science and latest research about obesity and renders the information imminently readable and immediately useful to the medical practitioner charged with providing best practices health care for patients who are obese. In the process, this text scientifically clarifies obesity as a disease
beta-carotene
发表于 2025-3-23 02:05:32
978-3-319-39407-7Springer International Publishing Switzerland 2016
红润
发表于 2025-3-23 06:50:44
http://reply.papertrans.cn/71/7002/700108/700108_10.png